{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T07:49:32Z","timestamp":1722152972736},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T00:00:00Z","timestamp":1466985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11606-016-3769-0","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T14:06:14Z","timestamp":1467122774000},"page":"1530-1536","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anti-MDA5-Positive Dermatomyositis Presenting as Fever of Unknown Origin"],"prefix":"10.1007","volume":"31","author":[{"given":"Lori W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neera S.","family":"Narang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Postolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Seminara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly A.","family":"Kantor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,27]]},"reference":[{"key":"3769_CR1","doi-asserted-by":"crossref","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, Mcclain KL. How I treat How I treat hemophagocytic lymphohistiocytosis. 2011;118:4041\u20134052.","DOI":"10.1182\/blood-2011-03-278127"},{"key":"3769_CR2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"J-I Henter","year":"2007","unstructured":"Henter J-I, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u2013131.","journal-title":"Pediatr Blood Cancer"},{"key":"3769_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kep078","volume":"48","author":"H Gunawardena","year":"2009","unstructured":"Gunawardena H, Betteridge ZE, McHugh NJ. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology. 2009;48:607\u2013612.","journal-title":"Rheumatology"},{"key":"3769_CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/03009740802687455","volume":"38","author":"K Fujikawa","year":"2009","unstructured":"Fujikawa K, et al. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155\/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study. Scand J Rheumatol. 2009;38:263\u2013267.","journal-title":"Scand J Rheumatol"},{"key":"3769_CR5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11926-002-0089-7","volume":"4","author":"IN Targoff","year":"2002","unstructured":"Targoff IN. Idiopathic inflammatory myopathy: autoantibody update. Curr Rheumatol Rep. 2002;4:434\u2013441.","journal-title":"Curr Rheumatol Rep"},{"key":"3769_CR6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2010.09.016","volume":"65","author":"D Fiorentino","year":"2011","unstructured":"Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol. 2011;65:25\u201334.","journal-title":"J Am Acad Dermatol"},{"key":"3769_CR7","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/acr.21985","volume":"65","author":"Z Chen","year":"2013","unstructured":"Chen Z, et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis. Arthritis Care Res. 2013;65:1316\u20131324.","journal-title":"Arthritis Care Res"},{"key":"3769_CR8","first-page":"1563","volume":"51","author":"T Gono","year":"2012","unstructured":"Gono T, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatol. (United Kingdom). 2012;51:1563\u20131570.","journal-title":"Rheumatol. (United Kingdom)"},{"key":"3769_CR9","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52:1571\u20131576.","journal-title":"Arthritis Rheum"},{"key":"3769_CR10","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60:2193\u20132200.","journal-title":"Arthritis Rheum"},{"key":"3769_CR11","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/BOR.0b013e32833f1987","volume":"22","author":"S Sato","year":"2010","unstructured":"Sato S, Kuwana M. Clinically amyopathic dermatomyositis. Curr Opin Rheumatol. 2010;22:639\u2013643.","journal-title":"Curr Opin Rheumatol"},{"key":"3769_CR12","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/acr.21728","volume":"64","author":"H Cao","year":"2012","unstructured":"Cao H, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res. 2012;64:1602\u20131610.","journal-title":"Arthritis Care Res"},{"key":"3769_CR13","doi-asserted-by":"crossref","unstructured":"Narang NS, Casciola-Rosen L, Li S, Chung L, Fiorentino DF. Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease. Arthritis Care Res. 2015; 67:667-672.","DOI":"10.1002\/acr.22498"},{"key":"3769_CR14","first-page":"1278","volume":"51","author":"T Koga","year":"2012","unstructured":"Koga T, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatol. (United Kingdom). 2012;51:1278\u20131284.","journal-title":"Rheumatol. (United Kingdom)"},{"key":"3769_CR15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/archdermatol.2011.52","volume":"147","author":"Y Hamaguchi","year":"2011","unstructured":"Hamaguchi Y, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol. 2011;147:391\u2013398.","journal-title":"Arch Dermatol"},{"key":"3769_CR16","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/keq149","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, et al. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology. 2010;49:1713\u20131719.","journal-title":"Rheumatology"},{"key":"3769_CR17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/acr.21992","volume":"65","author":"JC Hall","year":"2013","unstructured":"Hall JC, et al. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res. 2013;65:1307\u20131315.","journal-title":"Arthritis Care Res"},{"key":"3769_CR18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2009","unstructured":"Nakashima R, et al. The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology. 2009;49:433\u2013440.","journal-title":"Rheumatology"},{"key":"3769_CR19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.rmed.2011.05.006","volume":"105","author":"K Tanizawa","year":"2011","unstructured":"Tanizawa K, et al. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med. 2011;105:1380\u20131387.","journal-title":"Respir Med"},{"key":"3769_CR20","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1346-8138.2011.01262.x","volume":"38","author":"N Ikeda","year":"2011","unstructured":"Ikeda N, et al. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38:973\u2013979.","journal-title":"J Dermatol"},{"key":"3769_CR21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1196\/annals.1361.047","volume":"1051","author":"A Ponyi","year":"2005","unstructured":"Ponyi A, et al. Cancer-associated myositis: clinical features and prognostic signs. Ann N Y Acad Sci. 2005;1051:64\u201371.","journal-title":"Ann N Y Acad Sci"},{"key":"3769_CR22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrneurol.2011.63","volume":"7","author":"AL Mammen","year":"2011","unstructured":"Mammen AL. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis. Nat Rev Neurol. 2011;7:343\u2013354.","journal-title":"Nat Rev Neurol"},{"key":"3769_CR23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00000421-199602000-00008","volume":"19","author":"WJ Hu","year":"1996","unstructured":"Hu WJ, Chen DL, Min HQ. Study of 45 cases of nasopharyngeal carcinoma with dermatomyositis. Am J Clin Oncol. 1996;19:35\u201338.","journal-title":"Am J Clin Oncol"},{"key":"3769_CR24","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1365-2133.2009.09274.x","volume":"161","author":"YL Huang","year":"2009","unstructured":"Huang YL, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol. 2009;161:854\u2013860.","journal-title":"Br J Dermatol"},{"key":"3769_CR25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7326\/0003-4819-142-2-200501180-00010","volume":"142","author":"DA Redelmeier","year":"2005","unstructured":"Redelmeier DA. Improving patient care. The cognitive psychology of missed diagnoses. Ann Intern Med. 2005;142:115\u2013120.","journal-title":"Ann Intern Med"},{"key":"3769_CR26","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1518\/001872095779049543","volume":"37","author":"MR Endsley","year":"1995","unstructured":"Endsley MR. Toward a theory of situation awareness in dynamic systems. Hum Factors J Hum Factors Ergon Soc. 1995;37:32\u201364.","journal-title":"Hum Factors J Hum Factors Ergon Soc"},{"key":"3769_CR27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1518\/001872095779049444","volume":"37","author":"K Smith","year":"1995","unstructured":"Smith K, Hancock PA. Situation awareness is adaptive, externally directed consciousness. Hum Factors J Hum Factors Ergon Soc. 1995;37:137\u2013148.","journal-title":"Hum Factors J Hum Factors Ergon Soc"},{"key":"3769_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jbi.2007.02.001","volume":"40","author":"B Hazlehurst","year":"2007","unstructured":"Hazlehurst B, McMullen CK, Gorman PN. Distributed cognition in the heart room: how situation awareness arises from coordinated communications during cardiac surgery. J Biomed Inform. 2007;40:539\u2013551.","journal-title":"J Biomed Inform"},{"key":"3769_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0925-7535(01)00010-8","volume":"39","author":"NA Stanton","year":"2001","unstructured":"Stanton NA, Chambers PRG, Piggott J. Situational awareness and safety. Saf Sci. 2001;39:189\u2013204.","journal-title":"Saf Sci"},{"key":"3769_CR30","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1080\/00140130600612762","volume":"49","author":"NA Stanton","year":"2007","unstructured":"Stanton NA, et al. Distributed situation awareness in dynamic systems: theoretical development and application of an ergonomics methodology. Ergonomics. 2007;49:1288\u20131311.","journal-title":"Ergonomics"},{"key":"3769_CR31","first-page":"13","volume":"11","author":"PA Hancock","year":"2003","unstructured":"Hancock PA, Szalma JL. Operator stress and display design. Ergon Des. 2003;11:13\u201318.","journal-title":"Ergon Des"},{"key":"3769_CR32","unstructured":"Schiff GD, et al. Diagnosing diagnosis errors: lessons from a multi-institutional collaborative project. Advances in Patient Safety: From Research to Implementation, Agency for Healthcare Research and Quality, Rockville: MD (2007) vol 2. February 2005. AHRQ Publication No. 050021. Available at: http:\/\/www.ahrq.gov\/downloads\/pub\/advances\/vol2\/schiff.pdf.\/ . Accessed 16 June"},{"key":"3769_CR33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1037\/a0030730","volume":"142","author":"J Fukukura","year":"2012","unstructured":"Fukukura J, Ferguson MJ, Fujita K. Psychological distance can improve decision making under information overload via gist memory. J Exp Psychol Gen. 2012;142:658\u2013665.","journal-title":"J Exp Psychol Gen"},{"key":"3769_CR34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0165551508095781","volume":"35","author":"D Bawden","year":"2008","unstructured":"Bawden D, Robinson L. The dark side of information: overload, anxiety and other paradoxes and pathologies. J Inf Sci. 2008;35:180\u2013191.","journal-title":"J Inf Sci"},{"key":"3769_CR35","first-page":"353","volume":"93","author":"DO Case","year":"2005","unstructured":"Case DO, Andrews JE, Johnson JD, Allard SL. Avoiding versus seeking: the relationship of information seeking to avoidance, blunting, coping, dissonance, and related concepts. J Med Libr Assoc. 2005;93:353\u201362.","journal-title":"J Med Libr Assoc"},{"key":"3769_CR36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11606-007-0393-z","volume":"23","author":"H Singh","year":"2008","unstructured":"Singh H, Naik AD, Rao R, Petersen LA. Reducing diagnostic errors through effective communication: harnessing the power of information technology. J Gen Intern Med. 2008;23:489\u2013494.","journal-title":"J Gen Intern Med"},{"key":"3769_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0404.2010.01353.x","volume":"123","author":"A Jain","year":"2011","unstructured":"Jain A, et al. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis. Acta Neurol Scand. 2011;123:122\u2013129.","journal-title":"Acta Neurol Scand"},{"key":"3769_CR38","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/art.1780230802","volume":"23","author":"M Nishikai","year":"1980","unstructured":"Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies characterization of the Jo- 1 antibody system. Arthritis Rheum. 1980;23:881\u2013888.","journal-title":"Arthritis Rheum"},{"key":"3769_CR39","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.1780260505","volume":"26","author":"S Yoshida","year":"1983","unstructured":"Yoshida S, et al. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum. 1983;26:604\u2013611.","journal-title":"Arthritis Rheum"},{"key":"3769_CR40","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","volume":"12","author":"IN Targoff","year":"2000","unstructured":"Targoff IN. Update on myositis-specific and myositis-associated autoantibodies. Curr Opin Rheumatol. 2000;12:475\u2013481.","journal-title":"Curr Opin Rheumatol"},{"key":"3769_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-015-8513-8","author":"H Gunawardena","year":"2015","unstructured":"Gunawardena H. The clinical features of myositis-associated autoantibodies: a review. Clin Rev Allergy Immunol. 2015. doi: 10.1007\/s12016-015-8513-8 .","journal-title":"Clin Rev Allergy Immunol"},{"key":"3769_CR42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2217\/ijr.10.48","volume":"5","author":"R Nakashima","year":"2010","unstructured":"Nakashima R, Mimori T. Clinical and pathophysiological significance of myositis-specific and myositis-associated autoantibodies. Int J Clin Rheumatol. 2010;5:523\u2013536.","journal-title":"Int J Clin Rheumatol"},{"key":"3769_CR43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/art.1780280711","volume":"28","author":"IN Targoff","year":"1985","unstructured":"Targoff IN, Reichlin M. The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 1985;28:796\u2013803.","journal-title":"Arthritis Rheum"},{"key":"3769_CR44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","volume":"48\u201349","author":"L Iaccarino","year":"2014","unstructured":"Iaccarino L, et al. The clinical features, diagnosis and classification of dermatomyositis. J Autoimmun. 2014;48\u201349:122\u2013127.","journal-title":"J Autoimmun"},{"key":"3769_CR45","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00005792-199111000-00002","volume":"70","author":"LA Love","year":"1991","unstructured":"Love LA, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore). 1991;70:360\u2013374.","journal-title":"Medicine (Baltimore)"},{"key":"3769_CR46","first-page":"815","volume":"60","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, et al. Autoantibodies to the p140 autoantigen NXP-2 in adult dermatomyositis. Arthritis Rheum. 2009;60:815.","journal-title":"Arthritis Rheum"},{"key":"3769_CR47","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","volume":"65","author":"DF Fiorentino","year":"2013","unstructured":"Fiorentino DF, et al. Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1\u03b3. Arthritis Rheum. 2013;65:2954\u201362.","journal-title":"Arthritis Rheum"},{"key":"3769_CR48","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis. 2012;71:710\u2013713.","journal-title":"Ann Rheum Dis"},{"key":"3769_CR49","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1002\/art.22862","volume":"56","author":"Z Betteridge","year":"2007","unstructured":"Betteridge Z, Gunawardena H, North J, Slinn J, McHugh N. Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis. Arthritis Rheum. 2007;56:3132\u20137.","journal-title":"Arthritis Rheum"},{"key":"3769_CR50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jim.2012.07.019","volume":"384","author":"E Tarricone","year":"2012","unstructured":"Tarricone E, et al. Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort. J Immunol Methods. 2012;384:128\u2013134.","journal-title":"J Immunol Methods"},{"key":"3769_CR51","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-014-0060-4","volume":"5","author":"A Ghirardello","year":"2014","unstructured":"Ghirardello A, et al. Myositis autoantibodies and clinical phenotypes. Auto Immun Highlight. 2014;5:69\u201375.","journal-title":"Auto Immun Highlight"},{"key":"3769_CR52","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1136\/ard.2008.097162","volume":"68","author":"ZE Betteridge","year":"2009","unstructured":"Betteridge ZE, et al. Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis. Ann Rheum Dis. 2009;68:1621\u20135.","journal-title":"Ann Rheum Dis"},{"key":"3769_CR53","unstructured":"Fujimoto M, et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis. Arthritis Rheum. 2012;64:S97."},{"key":"3769_CR54","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/art.22164","volume":"54","author":"IN Targoff","year":"2006","unstructured":"Targoff IN, et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum. 2006;54:3682\u20133689.","journal-title":"Arthritis Rheum"},{"key":"3769_CR55","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/art.33403","volume":"64","author":"M Fujimoto","year":"2012","unstructured":"Fujimoto M, et al. Myositis-specific anti-155\/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012;64:513\u201322.","journal-title":"Arthritis Rheum"},{"key":"3769_CR56","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/art.33379","volume":"64","author":"E Trallero-Aragu\u00e1s","year":"2012","unstructured":"Trallero-Aragu\u00e1s E, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis. Arthritis Rheum. 2012;64:523\u2013532.","journal-title":"Arthritis Rheum"},{"key":"3769_CR57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/MD.0b013e3181ca14ff","volume":"89","author":"E Trallero-Aragu\u00e1s","year":"2010","unstructured":"Trallero-Aragu\u00e1s E, et al. Cancer-associated myositis and anti-p155 autoantibody in a series of 85 patients with idiopathic inflammatory myopathy. Medicine (Baltimore). 2010;89:47\u201352.","journal-title":"Medicine (Baltimore)"},{"key":"3769_CR58","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","volume":"47","author":"H Gunawardena","year":"2008","unstructured":"Gunawardena H, et al. Clinical associations of autoantibodies to a p155\/140\u00a0kDa doublet protein in juvenile dermatomyositis. Rheumatology (Oxford). 2008;47:324\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"3769_CR59","doi-asserted-by":"crossref","unstructured":"Mack A, Rock I. Inattentional Blindness. In: Malik J, Perona P, eds. Cambridge MA, MIT Press; 1998:7, 287","DOI":"10.7551\/mitpress\/3707.001.0001"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-016-3769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11606-016-3769-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-016-3769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T05:22:04Z","timestamp":1568092924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11606-016-3769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,27]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["3769"],"URL":"https:\/\/doi.org\/10.1007\/s11606-016-3769-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,27]]}}}